NCT00267189 - RESCUE Study - Everolimus in Liver Transplantation Recipients With Renal Insufficiency | Biotech Hunter

Enrollment

145

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions

Liver Transplantation

Interventions

DRUG

Everolimus

1.5 mg bid adjusted in order to achieve a trough level between 3 and 8 ng/mL while in combination with CNI and between 6 and 12 ng/mL after CNI discontinuation

DRUG

Calcineurin inhibitors (CNI)

DRUG

Mycophenolate acid (MPA)/ Azathioprine (AZA)

DRUG

Steroids

Trial Locations (2)

Unknown

Novartis Investigational Site, Germany

Novartis Investigative Site, Basel